How Long Does 2.5mg Mounjaro Last in Your Body?

Step 1, How the medicine builds and holds its level after you inject

Tirzepatide reaches its peak concentration in the blood roughly 24–72 hours after a subcutaneous injection. From that peak it falls slowly, because the half-life sits at around five days. By day seven, when your next dose is due, the level has dropped but has not cleared entirely. This overlap is deliberate: it keeps a baseline amount of the medicine active throughout the week and prevents a sharp drop-off in effect on days six and seven.

At 2.5mg the peak is lower than at any subsequent dose, which is why the effects you feel (modest appetite reduction, a slight slowing of how fast food leaves your stomach) may feel gentle, or in some cases barely noticeable at first. That is not a sign the medicine is not working. It is doing exactly what it is supposed to do at this stage. The full overview of Mounjaro explains the mechanism in more detail if you want the broader picture.

Practically speaking: inject on the same day each week, at any time of day that works for you. Consistency matters more than the exact hour. One thing worth noting, if your first injection falls on a bank holiday Monday or your pen arrives just after payday, the day of the week you choose at the start tends to stick, so it is worth picking something that fits your routine from the outset.

Step 2, What you may actually feel during the first four weeks

The 2.5mg period typically lasts four weeks, after which a prescriber reviews whether to increase the dose. During those four weeks, most people notice the medicine beginning to have some effect within the first few days. Appetite may feel slightly reduced, meals may feel satisfying faster, and some people notice a preference for smaller portions. Others feel very little at this dose, both are normal.

The side effects most commonly reported in the first weeks are gastrointestinal: nausea, loose stools, constipation, indigestion or burping. These tend to peak in the days immediately after an injection and usually ease as the week goes on. If you are still hungry and wondering whether the dose is doing anything, our dedicated page on hunger at 2.5mg walks through what is typical and what is not.

The NHS patient information for tirzepatide notes these gastrointestinal effects are the most frequently reported, and the NHS medicines page for tirzepatide lists them alongside guidance on when to contact a clinician. Keep that page bookmarked for the first month.

Step 3 (When the 2.5mg dose ends and what comes next

After four weeks at 2.5mg, the next clinical step is usually an increase to 5mg) subject to your prescriber's assessment. This is not automatic. A prescriber looks at tolerability, any side effects you have reported, and whether the current dose needs more time. The licensed schedule goes 2.5mg, 5mg, 7.5mg, 10mg, 12.5mg and 15mg, each step typically four weeks apart, but the pace is always tailored.

How long tirzepatide lasts at higher doses follows the same pharmacokinetic logic, the half-life does not change. What changes is the peak concentration and, with it, the strength of the effect. If you are curious how that plays out at the other end of the schedule, the page on how long 10mg tirzepatide lasts is a useful comparison.

It is also worth reading about whether 5mg works noticeably better than 2.5mg before your first review, so you know what questions to raise. And if you are thinking about what happens if a dose is delayed or missed entirely, the guidance on Mounjaro's last dose covers the practical considerations around gaps in treatment.

A note on cost and what is included in private treatment

Because Mounjaro is a prescription-only medicine, private pricing covers far more than the pen itself. A legitimate private service includes the clinical consultation, the prescription, any dose-review support, and delivery. What buying Mounjaro privately actually involves is worth understanding before you compare quotes from different providers, because headline figures do not always include the same things.

NICE's appraisal of tirzepatide (TA1026, published December 2024) confirmed its recommendation for NHS use under phased criteria. Private access through a regulated pharmacy remains an option for people who do not meet those criteria or prefer not to wait. A prescriber decides suitability; the 2.5mg dose is where that journey starts for everyone. If you would like to talk to our clinical team, you can start a free consultation and receive a same-day review from a GPhC-registered prescriber.